Švarameda - Company finances
|
EUR
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 11,496 | 3,344 | 3,814 | 12,541 | 7,003 |
| Profit before tax | -8,977 | -2,168 | -535 | 5,578 | -4,369 |
| Net profit | -8,977 | -2,168 | -535 | 5,481 | -4,369 |
| Equity | -8,876 | -11,045 | -11,580 | -9,540 | -13,909 |
| Liabilities | - | 15,121 | 15,186 | 17,675 | 16,180 |
| Non-current assets | 2,450 | 2,100 | 1,750 | 1,083 | 0 |
| Current assets | 4,309 | 1,976 | 1,856 | 7,052 | 2,271 |
| Total assets | 6,759 | 4,076 | 3,606 | 8,135 | 2,271 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 798 | 19 | 2,185 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -70.9% | +14.1% | +228.8% | -44.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -132.8% | -53.2% | -14.8% | 67.4% | -192.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -78.1% | -64.8% | -14.0% | 43.7% | -62.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -78.1% | -64.8% | -14.0% | 44.5% | -62.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,927 | 3,087 | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Švarameda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-02 | 2026-06-30 | 241.44 |
| 2026-05-03 | 2026-06-01 | 160.96 |
| 2026-04-20 | 2026-04-30 | 80.48 |
| 2024-05-15 | 2024-08-31 | 145.92 |
| 2023-07-19 | 2023-07-31 | 6.89 |
| 2022-06-16 | 2022-07-07 | 4.82 |
| 2022-02-17 | 2022-02-22 | 51.48 |
| 2022-01-18 | 2022-01-26 | 95.42 |
| 2021-12-16 | 2021-12-26 | 31.17 |
| 2021-11-16 | 2021-11-23 | 117.45 |
| 2021-10-18 | 2021-11-02 | 36.09 |
| 2021-09-17 | 2021-10-05 | 104.59 |
Švarameda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-03 | 2026-03-02 | 1.4 |
| 2026-01-27 | 2026-02-02 | 0.6 |
| 2026-01-09 | 2026-01-26 | 3.6 |
| 2026-01-01 | 2026-01-08 | 384.0 |
| 2025-12-23 | 2025-12-31 | 383.1 |
| 2025-12-01 | 2025-12-22 | 380.9 |
| 2025-11-28 | 2025-11-30 | 380.4 |
| 2025-07-03 | 2025-07-20 | 264.18 |
| 2025-07-01 | 2025-07-02 | 272.71 |
| 2025-06-30 | 2025-06-30 | 272.23 |
| 2025-06-27 | 2025-06-29 | 272.25 |
| 2025-06-19 | 2025-06-26 | 278.25 |
| 2025-06-06 | 2025-06-18 | 86.56 |
| 2025-04-28 | 2025-04-28 | 379.21 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Švarameda, MB (code 304484797) is a small partnership operating in other building and industrial cleaning activities. In the latest financial year, 2025, the company generated revenue of EUR 7.0K, down 44.2% year on year from EUR 12.5K in 2024. Net profit turned to a loss of EUR 4.4K in 2025, after a profit of EUR 5.5K in 2024 and a loss of EUR 535 in 2023. The 2025 profit margin was -62.4%, reflecting the weaker operating result. Over the three-year period, revenue rose from EUR 3.8K in 2023 to EUR 12.5K in 2024, then declined in 2025, while profitability was volatile. On the balance sheet, total assets fell to EUR 2.3K in 2025 from EUR 8.1K in 2024, while liabilities were EUR 16.2K and equity remained negative at EUR 13.9K below zero. The latest ratios should be interpreted carefully because of the negative equity base, but asset turnover was 3.08x in 2025, indicating revenue generation relative to the asset base.